2024 - Streamline Serological Testing Using Multiplexed Assays that Generate Multiple Results in a Single Test

Serological testing plays a pivotal role in understanding pre-existing immunity, infection and immunogenicity. However, conventional characterization assays often pose challenges in terms of complexity, time consumption and resource requirements, particularly when assessing antibody titers against multiple targets.
InDevR’s VaxArray® Platform addresses these logistical hurdles by simplifying and streamlining analytical development through its innovative, multiplexed microarray-based technology. This technology enables the generation of multiple results from a single test for high-value applicability to multivalent vaccines.
The VaxArray Platform comprises a versatile range of applications in serology and vaccine analytics, encompassing serum antibody quantification, identity testing, antigen quantification, characterization of nucleic acid vaccine constructs and assessment of cell-based potency assays for mRNA vaccines. InDevR’s off-the-shelf, multiplexed kits, alongside user-friendly instrumentation and data analysis tools, facilitate rapid sample processing with a typical turnaround time of less than 90 minutes.
In this webinar, the expert speaker will showcase the utility of the VaxArray Platform in serological testing, emphasizing its distinctive advantages in this field compared to traditional approaches. They will also focus on off-the-shelf kits tailored for COVID serological testing and serological applications for pneumococcal conjugate vaccines, in addition to a review of corresponding data. Additionally, the speaker will discuss about custom kit development for serological testing, including specific examples of custom serology projects.
Register for this webinar today to gain insights into the transformative capabilities of an innovative, multiplexed microarray-based technology for serological testing and vaccine analytics.
Keywords: Vaccine, Antibodies, Antibody, CRO, Cell Therapy, Biomarkers, Marketing, Monoclonal Antibodies, Laboratory Technology, Vaccine Development, Bioanalytical Testing, Cell & Gene Therapies, CDMO/CMO, Basic Research, CGT